real-world daratumumab monotherapy
Published 4 years ago • 341 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
1:08
an overview of daratumumab monotherapy for heavily treated multiple myeloma
-
2:42
final results of the dart4mm study of daratumumab for mrd eradication in myeloma
-
3:25
final analysis of centaurus: daratumumab monotherapy for smm
-
0:52
the future of daratumumab in multiple myeloma
-
1:27
the real world utilization of mrd in myeloma across europe
-
17:55
talquetamab | therapies on the horizon #myeloma
-
6:07
magnetismm-3: elranatamab in r/r multiple myeloma naive to bcma-directed therapy
-
15:43
elranatamab - upcoming myeloma therapy
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
1:18
standardizing mrd techniques after fda approval as a surrogate endpoint in myeloma trials
-
1:47
real-world safety and efficacy of talquetamab for the treatment of r/r myeloma
-
1:25
real world data: bortezomib-based therapy for r/r myeloma
-
1:30
real-world insight for myeloma
-
2:00
real-world bortezomib prescribing patterns and outcomes in ndmm
-
1:43
real-world outcomes of teclistamab for r/r multiple myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
1:47
abnormal serum immunofixation patterns following bcma car-t in multiple myeloma
-
2:01
real-world results of an in-class transition from vrd to ird in myeloma
-
2:46
the impact of daratumumab on the myeloma treatment landscape